Back to Journals » Lung Cancer: Targets and Therapy

Lung Cancer: Targets and Therapy


Journal Articles:

- 93 records -

65Plus: open-label study of bevacizumab in combination with pemetrexed or pemetrexed/carboplatin as first-line treatment of patients with advanced or recurrent nonsquamous non-small-cell lung cancer

Schuette W, Schneider CP, Engel-Riedel W, Schumann C, Kohlhaeufl M, Serke MHU, Hoeffken G, Kortsik C, Reck M

Lung Cancer: Targets and Therapy 2017, 8:217-229

Published Date: 6 November 2017

nab-paclitaxel/carboplatin induction in squamous NSCLC: longitudinal quality of life while on chemotherapy

Thomas M, Spigel DR, Jotte RM, McCleod M, Socinski MA, Page RD, Gressot L, Knoble J, Juan O, Morgensztern D, Isla D, Kim ES, West H, Ko A, Ong TJ, Trunova N, Gridelli C

Lung Cancer: Targets and Therapy 2017, 8:207-216

Published Date: 30 October 2017

Real-world practice patterns for patients with advanced non-small cell lung cancer: multicenter retrospective cohort study in Japan

Isobe H, Mori K, Minato K, Katsura H, Taniguchi K, Arunachalam A, Kothari S, Cao X, Kato T

Lung Cancer: Targets and Therapy 2017, 8:191-206

Published Date: 24 October 2017

EGFR T790M: revealing the secrets of a gatekeeper

Ko B, Paucar D, Halmos B

Lung Cancer: Targets and Therapy 2017, 8:147-159

Published Date: 9 October 2017

Proton beam therapy in non-small cell lung cancer: state of the art

Harada H, Murayama S

Lung Cancer: Targets and Therapy 2017, 8:141-145

Published Date: 23 August 2017

Clinical staging of malignant pleural mesothelioma: current perspectives

Bonomi M, De Filippis C, Lopci E, Gianoncelli L, Rizzardi G, Cerchiaro E, Bortolotti L, Zanello A, Ceresoli GL

Lung Cancer: Targets and Therapy 2017, 8:127-139

Published Date: 18 August 2017

Osimertinib in the treatment of non-small-cell lung cancer: design, development and place in therapy

Santarpia M, Liguori A, Karachaliou N, Gonzalez-Cao M, Daffinà MG, D'Aveni A, Marabello G, Altavilla G, Rosell R

Lung Cancer: Targets and Therapy 2017, 8:109-125

Published Date: 18 August 2017

Chronic obstructive pulmonary disease in patients with lung cancer: prevalence, impact and management challenges

Spyratos D, Papadaki E, Lampaki S, Kontakiotis T

Lung Cancer: Targets and Therapy 2017, 8:101-107

Published Date: 7 August 2017

New prognostic biomarkers and therapeutic effect of bevacizumab for patients with non-small-cell lung cancer

Niki M, Yokoi T, Kurata T, Nomura S

Lung Cancer: Targets and Therapy 2017, 8:91-99

Published Date: 3 August 2017

New PD-L1 inhibitors in non-small cell lung cancer – impact of atezolizumab

Seetharamu N, Preeshagul IR, Sullivan KM

Lung Cancer: Targets and Therapy 2017, 8:67-78

Published Date: 13 July 2017

Spotlight on ramucirumab in the treatment of nonsmall cell lung cancer: design, development, and clinical activity

Cobo M, Gutiérrez V, Villatoro R, Trigo JM, Ramos I, López O, Ruiz M, Godoy A, López I, Arroyo M

Lung Cancer: Targets and Therapy 2017, 8:57-66

Published Date: 12 July 2017

Detection of ROS1 rearrangement in non-small cell lung cancer: current and future perspectives

Rossi G, Jocollé G, Conti A, Tiseo M, Zito Marino F, Donati G, Franco R, Bono F, Barbisan F, Facchinetti F

Lung Cancer: Targets and Therapy 2017, 8:45-55

Published Date: 7 July 2017

A pilot study of zoledronic acid in the treatment of patients with advanced malignant pleural mesothelioma

Jamil MO, Jerome MS, Miley D, Selander KS, Robert F

Lung Cancer: Targets and Therapy 2017, 8:39-44

Published Date: 12 June 2017

Spotlight on necitumumab in the treatment of non-small-cell lung carcinoma

Thakur MK, Wozniak AJ

Lung Cancer: Targets and Therapy 2017, 8:13-19

Published Date: 13 February 2017

Driver oncogenes in Sub-Saharan African patients with non-small cell lung cancer

Legius B, Van Den Broecke S, Muylle I, Ninane V

Lung Cancer: Targets and Therapy 2016, 7:149-152

Published Date: 30 November 2016

Lung cancer in Brazil: epidemiology and treatment challenges

de Sá VK, Coelho JC, Capelozzi VL, Azevedo SJ

Lung Cancer: Targets and Therapy 2016, 7:141-148

Published Date: 14 November 2016

Oligometastatic non-small-cell lung cancer: current treatment strategies

Richard PJ, Rengan R

Lung Cancer: Targets and Therapy 2016, 7:129-140

Published Date: 4 November 2016

Radiation-induced esophagitis in lung cancer

Baker S, Fairchild A

Lung Cancer: Targets and Therapy 2016, 7:119-127

Published Date: 13 October 2016

Outcomes and prognostic factors of chemotherapy for patients with locally advanced or metastatic pulmonary squamous cell carcinoma

Minami S, Ogata Y, Ihara S, Yamamoto S, Komuta K

Lung Cancer: Targets and Therapy 2016, 7:99-110

Published Date: 24 August 2016

Fatigue in lung cancer patients: symptom burden and management of challenges

Carnio S, Di Stefano RF, Novello S

Lung Cancer: Targets and Therapy 2016, 7:73-82

Published Date: 9 May 2016

Modern management of malignant pleural mesothelioma

Patel SC, Dowell JE

Lung Cancer: Targets and Therapy 2016, 7:63-72

Published Date: 3 May 2016

High expression of AKR1C1 is associated with proliferation and migration of small-cell lung cancer cells

Tian H, Li X, Jiang W, Lv C, Sun W, Huang C, Chen R

Lung Cancer: Targets and Therapy 2016, 7:53-61

Published Date: 2 May 2016

Retrospective analysis of outcomes and prognostic factors of chemotherapy for small-cell lung cancer

Minami S, Ogata Y, Ihara S, Yamamoto S, Komuta K

Lung Cancer: Targets and Therapy 2016, 7:35-44

Published Date: 5 April 2016

Optimal delivery of follow-up care following pulmonary lobectomy for lung cancer

Chen YY, Huang TW, Chang H, Lee SC

Lung Cancer: Targets and Therapy 2016, 7:29-34

Published Date: 30 March 2016

miRNA-21 as a novel therapeutic target in lung cancer

Markou A, Zavridou M, Lianidou ES

Lung Cancer: Targets and Therapy 2016, 7:19-27

Published Date: 2 March 2016

HSP90 as a novel molecular target in non-small-cell lung cancer

Esfahani K, Cohen V

Lung Cancer: Targets and Therapy 2016, 7:11-17

Published Date: 1 March 2016

Epiregulin as a therapeutic target in non-small-cell lung cancer

Sunaga N, Kaira K

Lung Cancer: Targets and Therapy 2015, 6:91-98

Published Date: 12 October 2015

Combination chemotherapy of gemcitabine and vinorelbine for pretreated non-small- cell lung cancer: a retrospective study

Minami S, Ogata Y, Yamamoto S, Komuta K

Lung Cancer: Targets and Therapy 2015, 6:83-90

Published Date: 25 September 2015

First-line treatment of advanced ALK-positive non-small-cell lung cancer

Gandhi S, Chen H, Zhao Y, Dy GK

Lung Cancer: Targets and Therapy 2015, 6:71-82

Published Date: 18 September 2015

Targeting PD-1/PD-L1 in lung cancer: current perspectives

González-Cao M, Karachaliou N, Viteri S, Morales-Espinosa D, Teixidó C, Sánchez Ruiz J, Molina-Vila MÁ, Santarpia M, Rosell R

Lung Cancer: Targets and Therapy 2015, 6:55-70

Published Date: 31 July 2015

Non-small-cell lung carcinoma: role of the Notch signaling pathway

Barse L, Bocchetta M

Lung Cancer: Targets and Therapy 2015, 6:43-53

Published Date: 26 June 2015

AXL receptor tyrosine kinase as a therapeutic target in NSCLC

Okimoto RA, Bivona TG

Lung Cancer: Targets and Therapy 2015, 6:27-34

Published Date: 30 April 2015

Hapten-enhanced therapeutic effect in advanced stages of lung cancer by ultra-minimum incision personalized intratumoral chemoimmunotherapy therapy

Yu BF, Lu YF, Gao F, Jing P, Han W, Zhang PC, Liu GL, Ru N, Cui GH, Xu XH, Sun CL, Guan CJ, Che YB, Wu YL, Ma ZL, Fu Q, Liu J, Wang HY

Lung Cancer: Targets and Therapy 2015, 6:1-11

Published Date: 7 January 2015

Staging lung cancer: role of endobronchial ultrasound

Inage T, Nakajima T, Yoshino I

Lung Cancer: Targets and Therapy 2014, 5:67-72

Published Date: 4 November 2014

The voice of postsurgical lung cancer patients regarding supportive care needs

Hoffman AJ, Brintnall RA, von Eye A, Cooper J, Brown JK

Lung Cancer: Targets and Therapy 2014, 5:21-31

Published Date: 28 April 2014

Gastroesophageal junction adenocarcinoma displays abnormalities in homologous recombination and nucleotide excision repair

Dewalt RI, Kesler KA, Hammoud ZT, Baldridge L, Hattab EM, Jalal SI

Lung Cancer: Targets and Therapy 2014, 5:11-20

Published Date: 15 February 2014

Potential toxicity and safety evaluation of nanomaterials for the respiratory system and lung cancer

Vlachogianni T, Fiotakis K, Loridas S, Perdicaris S, Valavanidis A

Lung Cancer: Targets and Therapy 2013, 4:71-82

Published Date: 27 November 2013

Practical management of NSCLC patients with long-term bevacizumab treatment: a report of four cases

Herder GJM, Codrington H, Colder CD, Aerts JG

Lung Cancer: Targets and Therapy 2013, 4:55-59

Published Date: 11 October 2013

Robotic stereotactic body radiation therapy for elderly medically inoperable early-stage non-small cell lung cancer

Karam SD, Horne ZD, Hong RL, Baig N, Gagnon GJ, McRae D, Duhamel D, Nasr NM

Lung Cancer: Targets and Therapy 2013, 4:35-42

Published Date: 7 August 2013

EGFR mutations in patients with lung adenocarcinoma in southwest China: are G719S/A and L861Q more likely detected in tumors derived from smokers?

Wang QS, Mou JH, Yang X, He Y, Li ZP, Luo QY, Li YQ, Lin L, Ma Y, Xiao HL

Lung Cancer: Targets and Therapy 2013, 4:27-33

Published Date: 1 July 2013

MET overexpression and gene amplification in NSCLC: a clinical perspective

Landi L, Minuti G, D'Incecco A, Salvini J, Cappuzzo F

Lung Cancer: Targets and Therapy 2013, 4:15-25

Published Date: 19 June 2013

Gefitinib frequently induces liver damage in patients with lung adenocarcinoma previously treated by chemotherapy

Sugiura Y, Nemoto E, Kawai O, Ohkubo Y, Fusegawa H, Kaseda S

Lung Cancer: Targets and Therapy 2013, 4:9-14

Published Date: 10 June 2013

Targeted inhibition in tumors with ALK dependency

Kwak EL, Clark JW, Shaw AT

Lung Cancer: Targets and Therapy 2013, 4:1-8

Published Date: 10 January 2013

Lung cancer in women

Barrera-Rodriguez R, Morales-Fuentes J

Lung Cancer: Targets and Therapy 2012, 3:79-89

Published Date: 17 December 2012

Association of p21 Ser31Arg and p53 Arg72Pro polymorphisms with lung cancer risk in CAPUA study

Souto-García A, Fernández-Somoano A, Pascual T, Álvarez-Avellón SM, Tardón A

Lung Cancer: Targets and Therapy 2012, 3:69-78

Published Date: 22 November 2012

Non-small cell lung cancer: the era of targeted therapy

Antonoff MB, D'Cunha J

Lung Cancer: Targets and Therapy 2012, 3:31-41

Published Date: 3 July 2012

Update on biomarkers for the detection of lung cancer

Jantus-Lewintre E, Usó M, Sanmartín E, Camps C

Lung Cancer: Targets and Therapy 2012, 3:21-29

Published Date: 12 June 2012

Afatinib treatment in advanced non-small cell lung cancer

Hurwitz JL, Scullin P, Campbell L

Lung Cancer: Targets and Therapy 2011, 2:47-57

Published Date: 7 October 2011

Effectiveness of maintenance treatments for nonsmall cell lung cancer

Eadens MJ, Robinson SI, Price KA

Lung Cancer: Targets and Therapy 2011, 2:29-39

Published Date: 22 July 2011

Emerging treatment options in the management of non-small cell lung cancer

Filosso PL, Sandri A, Oliaro A, Filippi AR, Cassinis MC, Ricardi U, Lausi P, Asioli S, Ruffini E

Lung Cancer: Targets and Therapy 2011, 2:11-28

Published Date: 8 June 2011

Efficacy and safety of erlotinib in the treatment of metastatic non-small-cell lung cancer

Serena Ricciardi, Silverio Tomao, Filippo de Marinis

Lung Cancer: Targets and Therapy 2011, 2:1-9

Published Date: 20 December 2010

Dyspnea in lung cancer patients: a systematic review

Ganesan Kathiresan, Reynold F Clement, Meera T Sankaranarayanan

Lung Cancer: Targets and Therapy 2010, 1:141-150

Published Date: 23 November 2010

Azacitidine and decitabine have different mechanisms of action in non-small cell lung cancer cell lines

Aaron N Nguyen, Paul W Hollenbach, Normand Richard, et al

Lung Cancer: Targets and Therapy 2010, 1:119-140

Published Date: 10 September 2010

Genome-wide gene expression analysis of chemoresistant pulmonary carcinoid cells

Ulrike Olszewski, Robert Zeillinger, Klaus Geissler, et al

Lung Cancer: Targets and Therapy 2010, 1:107-117

Published Date: 6 September 2010

The role of maintenance pemetrexed in the treatment of non-small-cell lung cancer

Saeed Rafii, Michael H Cullen

Lung Cancer: Targets and Therapy 2010, 1:101-106

Published Date: 30 July 2010

Circulating tumor cells (CTCs) in lung cancer: current status and future perspectives

Fumihiro Tanaka, Kazue Yoneda, Seiki Hasegawa

Lung Cancer: Targets and Therapy 2010, 1:77-84

Published Date: 7 July 2010

Docetaxel in the treatment of non-small cell lung carcinoma: an update and analysis

Matthew A Gubens, Heather A Wakelee

Lung Cancer: Targets and Therapy 2010, 1:63-76

Published Date: 16 June 2010

Drug resistance in lung cancer

Manish Shanker, David Willcutts, Jack A Roth, et al

Lung Cancer: Targets and Therapy 2010, 1:23-36

Published Date: 13 May 2010

Refining the treatment of advanced nonsmall cell lung cancer

Shin Ogita, Antoinette J Wozniak

Lung Cancer: Targets and Therapy 2010, 1:9-22

Published Date: 4 May 2010